Table 2.

Patient follow-up and assessment schedule

Steps	Preinclusion	Inclusion	Follow-up to 6 months	Follow-up to 12 months	End of study
Moment	D-30 to D-15	D0	M6±15 days	M12±15 days	M12±15 days
Steps
Patient information	X
Clinical examination		X	X	X	X
Collection of informed consent		X
Verification of inclusion criteria	X	X
Psychiatric history	X
Written informed consent		X
Randomisation		X
Use of the application		X	X	X	X
Evaluation of efficacy		X	X	X
PSP Scale		X	X	X
Number of days in hospital			X	X
SES		X	X	X
WAI		X	X	X
MARS		X	X	X
PANSS		X	X	X
STORI		X	X	X
S-QoL 18		X	X	X
PAM (empowerment)		X	X	X
Satisfaction (VAS)		X	X	X
Search for adverse events		X	X	X	X
Evaluation of implementation in practice
Acceptability	X	X	X	X
Reliability	X	X	X	X
Use in practice	X	X	X	X
Semistructured interviews (case manager patients)					X

MARS, Medication Adherence Rating Scale; PAM, Patient Activation Measure; PANSS, Positive and Negative Syndrome Scale; PSP, Personal and Social Performance; SES, Service Engagement Scale; S-QoL 18, Schizophrenia Quality of Life Questionnaire Short Form; STORI, Stages of Recovery Instrument; VAS, Visual Analogue Scale; WAI, Working Alliance Inventory.